Pineridge Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Pineridge Advisors's ACLS Position: Q1 2025 in Review
Pineridge Advisors sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 7 shares — an estimated $489 sold.
Pineridge Advisors first reported a position in ACLS in Q4 2023 and held it in 5 quarters. The position peaked at $5.32K in Q4 2023. 307 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.
- Pineridge Advisors reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
- Pineridge Advisors sold 7 Axcelis shares in Q1 2025, an estimated $489.
- Pineridge Advisors first reported a position in Axcelis in Q4 2023 and held it in 5 quarters.
- Pineridge Advisors's Axcelis position peaked at $5.32K in Q4 2023.
- 307 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.
Based on Pineridge Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.